Clinical Trials Directory

Trials / Unknown

UnknownNCT05351385

S Protein and COVID-19: a Monocentric Prospective Study

Status
Unknown
Phase
Study type
Observational
Enrollment
70 (estimated)
Sponsor
University of Milano Bicocca · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The aim of this study is to compare plasma S Protein levels to SARS-CoV-2 viral load in COVID positive patients.

Detailed description

Non-pharmacological, non-interventional, prospective, monocentric study involving the use of biological materials. There will be two cohorts: * COVID + cohort: 50 patients with positive nasopharyngeal swab and / or BAL. * Control Cohort: 20 patients with non-SARS-CoV-2 related pneumonia. The study involves analyzing biological samples collected for normal clinical practice. In particular: * blood samples will be used for PROS and Sflt1 assay, haematological, biochemical and coagulation tests. * Samples deriving from nasopharyngeal swab or from Broncho-Alveolar Lavage (BAL) liquid will be used for Real time PCR analysis to evaluate the viral load of SARS CoV-2.

Conditions

Interventions

TypeNameDescription
PROCEDUREHematolgy and Chemistry analysisSamples will be collected at Day 0, Day 5, Day 10 and Day 15
PROCEDUREReal Time PCRSamples will be collected at Day 0, Day 5, Day 10 and Day 15
PROCEDUREPROS assay COVID+Samples will be collected at Day 0, Day 5, Day 10 and Day 15
PROCEDURESflt1 assay COVID+Samples will be collected at Day 0 and Day 10
PROCEDUREPROS assay CONTROLSamples will be collected at Day 0 (+5)
PROCEDURESflt1 assay CONTROLSamples will be collected at Day 0 (+5)

Timeline

Start date
2021-09-23
Primary completion
2022-06-03
Completion
2024-12-03
First posted
2022-04-28
Last updated
2024-01-02

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT05351385. Inclusion in this directory is not an endorsement.